Mi Ryung Roh

Dr. Mi Ryung Roh

orcid

Research Focus & Metrics

Academic Career Length

23Years (2004-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2014 in Annals of Dermatology
Verified
Journal Article
Open access
PDF file
YCYuri Choi
Yuri Choi
JLJi Hye Lee
Ji Hye Lee
YKYeon Hee Kim
Yeon Hee Kim
YLYong Sang Lee
Yong Sang Lee
HCHang-Seok Chang
Hang-Seok Chang
MRMi Ryung Roh
Mi Ryung Roh
Choi Y, et al. Ann Dermatol. 2014 Dec;26(6):693-699. http://dx.doi.org/10.5021/ad.2014.26.6.693

24 August 2015 in Pigment Cell & Melanoma Research
Verified
Journal Article
Open access
PDF file
MRMi Ryung Roh
Mi Ryung Roh
PEPhilip Eliades
Philip Eliades
SGSameer Gupta
Sameer Gupta
HTHensin Tsao
Hensin Tsao
Summary: Melanocytic nevi are a benign clonal proliferation of cells expressing the melanocytic phenotype, with heterogeneous clinical and molecular characteristics. In this review, we discuss the genetics of nevi by salient nevi subtypes: congenital melanocytic nevi, acquired melanocytic nevi, blue nevi, and Spitz nevi. While the molecular etiology of nevi has been less thoroughly studied than melanoma, it is clear that nevi and melanoma share common driver mutations. Acquired melanocytic nevi harbor oncogenic mutations in BRAF, which is the predominant oncogene associated with melanoma. Congenital melanocytic nevi and blue nevi frequently harbor NRAS mutations and GNAQ mutations, respectively, while Spitz and atypical Spitz tumors often exhibit HRAS and kinase rearrangements. These initial ‘driver’ mutations are thought to trigger the establishment of benign nevi. After this initial phase of the cell proliferation, a senescence program is executed, causing termination of nevi growth. Only upon the emergence of additional tumorigenic alterations, which may provide an escape from oncogene‐induced senescence, can malignant progression occur. Here, we review the current literature on the pathobiology and genetics of nevi in the hope that additional studies of nevi promise to inform our understanding of the transition from benign neoplasm to malignancy.

10 August 2006 in British Journal of Dermatology
Verified
Journal Article
Closed access
PDF file
MRMi Ryung Roh
Mi Ryung Roh
MHM. Han
M. Han
DKD. Kim
D. Kim
KCK. Chung
K. Chung

1 August 2009 in Dermatologic Surgery
Verified
Journal Article
Closed access
PDF file
MRMi Ryung Roh
Mi Ryung Roh
KCKee Yang Chung
Kee Yang Chung
Infraorbital dark circles refer to the conditions that present with darkness of the infraorbital eyelids. Although it is not a medical concern, it can be a cosmetic concern for a large number of individuals. Moreover, clear definition and possible causes have not been elucidated. To review the possible causes and treatment options for infraorbital dark circles. The article is based on a review of the medical literature and the author's clinical experience in treating infraorbital dark circles. Possible causative factors of infraorbital dark circles include excessive pigmentation, thin and translucent lower eyelid skin overlying the orbicularis oculi muscle, and shadowing due to skin laxity and tear trough, but because multiple factors cause infraorbital dark circles in the majority of patients, it is essential to identify the cause and choose the appropriate treatment according to the cause.

1 April 2013 in Journal of the American Academy of Dermatology
Verified
Journal Article
Closed access
JBJung Min Bae
Jung Min Bae
YCYoon Young Choi
Yoon Young Choi
HKHeesu Kim
Heesu Kim
BOByungho Oh
Byungho Oh
MRMi Ryung Roh
Mi Ryung Roh
KCKee Yang Chung
Kee Yang Chung

1 November 2020 in Journal of Investigative Dermatology
Verified
Journal Article
Closed access
YKYuanyuan Kang
Yuanyuan Kang
MRMi Ryung Roh
Mi Ryung Roh
SRSuvi Rajadurai
Suvi Rajadurai
ARAnpuchchelvi Rajadurai
Anpuchchelvi Rajadurai
RKRaj Kumar
Raj Kumar
HTHensin Tsao
Hensin Tsao